2026. Tralokinumab Treatment In Patients With Atopic Dermatitis and Moderate-to-Severe Hand Involvement: Results From the 32-week Phase 3b ADHAND Trial. SKIN The Journal of Cutaneous Medicine. 10, 2 (Mar. 2026), s744. DOI:https://doi.org/10.25251/ppt8ep84.